The Whitehead Institute said last week that Susan Lindquist will resign as president effective “on or about” Nov. 1. The institute said that Lindquist intends to focus on her laboratory and research.


Russell Ellison, chief medical officer and vice president of medical affairs at Sanofi-Synthelabo, has joined the board of ProSanos. Ellison has also held senior-level positions at Hoffmann La Roche, Roche Canada, and Glaxo Canada.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.